ABSTRACT
A novel benzopyran-based platinum (II)-3-hydroxy-2-tolyl-4H-chromen-4-one (HToC) complex has been prepared and studied by UV-visible spectrophotometry. The study is based on the colored complexation between Pt(II) and HToC in the pH range of 8.92-9.21, resulting in the formation of a stable binary yellow complex exhibiting λmax at 509-525 nm. The formed complex maintains linearity between 0.0 and 1.8 µg Pt(II) mL-1. The well-known qualitative analytical methods, including Job's method of continuous variations and the mole ratio approach, have both proven that the stoichiometry of the complex is 1:2 [Pt(II)/HToC]. Hence, the analytical results suggest that the formed platinum complex exhibits a square planar geometry. The values of various attributes corresponding to spectrophotometric studies and statistical calculations, such as the molar extinction coefficient (6.790 × 104 L mol-1 cm-1), Sandell's sensitivity (0.0029 µg Pt(II) cm-2), standard deviation (± 0.0011), RSD (0.317%), limit of detection (0.0147 µg mL-1) and correlation coefficient (0.9999), show that the performed study satisfies all of the criteria for good sensitivity, versatility, and cost-effectiveness. In order to have an apprehension of the molecular geometry and other structural specifics of the complex, DFT studies have been carried out. The in vitro anticancer potential of the ligand and its platinum complex in the human breast cancer cell line (T-27D), as determined by the MTT assay, reveals that the complex has better antiproliferative potential than the ligand. The antimicrobial potential of the complex has been successfully tested against both Gram-positive and -negative bacteria. Antioxidant capacity results suggest the better radical scavenging capacity of the complex than that of the ligand.
ABSTRACT
[This corrects the article DOI: 10.3389/fphar.2022.945323.].
ABSTRACT
A comprehensive aqueous phase spectrophotometric study concerning the trace level determination of iridium (III) by its reaction with benzopyran-derived chromogenic reagent, 6-chloro-3-hydroxy-7-methyl-2-(2'-thienyl)-4-oxo-4H-1-benzopyran (CHMTB), is performed. The complexing reagent instantly forms a yellow complex with Ir (III) at pH 4.63, where metal is bound to the ligand in a ratio of 1:2 as deduced by Job's continuous variations, mole ratio, and equilibrium shift methods. The complex absorbs maximally at 413-420 nm retaining its stability for up to 4 days. An optimum set of conditions have been set with respect to the parameters governing the formation of the complex. Under the set optimal conditions, the Ir (III)-CHMTB complex coheres to Beer's law between 0.0 and 1.5 µg Ir (III) mL-1. The attenuation coefficient and Sandell's sensitivity are, respectively, 1.18×105 L mol-1 cm-1 and 0.00162 µg cm-2 at 415 nm. The correlation coefficient (r) and standard deviation (SD) were 0.9999 and ± 0.001095, respectively, whereas the detection limit as analyzed was 0.007437 µg ml-1. The interference with respect to analytically important cations and complexing agents has been studied thoroughly. It is found that the majority of the ions/agents do not intervene with the formation of the complex, thus adding to the versatility of the method. The results obtained from the aforesaid studies indicate a simple, fast, convenient, sensitive, and versatile method for microgram analysis of iridium (III) using CHMTB as a binding ligand. Furthermore, the studied complex is subjected to the evaluation of antibacterial and antioxidant capacity by employing the Agar Diffusion assay and DPPH. radical scavenging method, respectively. The results obtained from the mentioned assays reveal that the investigated complex possesses significant potency as an antibacterial and antioxidant agent. Finally, the computational approach through DFT of the formed complex confirmed the associated electronic properties of the studied complex.
